SNCA and Parkinson disease: Interestingly, lowering toxicity by YDJ1 deletion appeared to be specific for Abeta42, as deletion of YDJ1 did not reduce alpha‐synuclein‐induced cell death (Fig EV1I) in a yeast model for Parkinson’s disease (Büttner et al, 2008).